IDEAYA Biosciences is listed on the Nasdaq exchange, and major financial firms are issuing rating updates and price targets regarding its stock.
4 reports, 2 independent
Updated Jul 27
Gone quiet
- Reports
- 4
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
IDEAYA Biosciences is listed on the Nasdaq exchange, and major financial firms are issuing rating updates and price targets regarding its stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Investment activity regarding IDEAYA Biosciences shows Pictet Asset Management and various hedge funds reduced holdings by 2.5% in Q1 and acquired new stakes in Q3.Sub-event
IDEAYA Biosciences stock receives rating updates from firms like Wedbush, Wells Fargo, Goldman Sachs, and Mizuho.1 source
IDEAYA Biosciences listed on Nasdaq from its base in South San Francisco.1 source
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
Wedbush Securities
US financial services and investment firm
Nothing else this week.
-
South San Francisco
city in San Mateo County, California, United States
Related events
- BioHarvest Sciences Inc is listed on the Nasdaq stock exchange and is receiving analyst ratings and targets from MarketBeat.
- Evelo Biosciences listed its stock on the Nasdaq exchange on August 1, 2026.
- Artelo Biosciences, Inc. listed its shares on the Nasdaq stock exchange on August 1, 2026.
- Advanced Biomed Inc. was listed on the Nasdaq exchange on September 4, 2026.
- Generate Biomedicines Inc listed its shares on the Nasdaq stock exchange on August 25, 2026.
Coverage
Newest first; wire copies grouped- prnewswire.comIDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers
- dailypolitical.com
- dailypolitical.com
- prnewswire.com